
About Meghmani Organics Limited
Data last updated:
Meghmani Organics Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the crop protection segment of the agriculture sector. It was incorporated on 15 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24299GJ2019PLC110321. Its GSTIN is 24AANCM0056E1ZR (Gujarat). The company holds 21 GST registrations, of which 18 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 543331 and NSE: MOL.
The company has an authorised share capital of ₹37 Cr and a paid-up capital of ₹25.43 Cr. It was formerly known as Meghmani Organochem Limited. It is led by directors including Ankit Natwarlal Patel (Managing Director) and Karana Rameshbhai Patel (Whole-Time Director).
Its last annual general meeting (AGM) was held on 28 June 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 1St2Nd3Rd Fl Nr. Raj Bunglow Nr.Safal Profitaire Prahlad Nagar Satellite, Ahmedabad, Gujarat, India – 380015.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹2,173.96 Cr, a growth of 4.5% compared to the previous year. For the same year it recorded a net profit of ₹29.12 Cr (net margin 1.3%) and EBITDA of ₹176.44 Cr (EBITDA margin 8.1%). The net worth stands at ₹1,544.78 Cr (up 1.9% YoY). Total assets are valued at ₹2,303.82 Cr (down 2.8% YoY).
The company has about 1,701 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 2 brands: Epigral and Meghmani Organics Ltd. As per MCA filings, the company has open charges of ₹2,264.9 Cr and satisfied charges of ₹234 Cr on record. Court records list 324 cases involving the company, including 229 filed by the company and 95 filed against it; 80 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website meghmani.com.
Company details
CIN history
Meghmani Organics has one previous CIN (Corporate Identification Number): U24299GJ2019PLC110321. The current CIN is L24299GJ2019PLC110321, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24299GJ2019PLC110321 | Current |
| U24299GJ2019PLC110321 | Previous |
Contact details
Meghmani Organics Limited's registered office is in Ahmedabad, Gujarat. Its website is meghmani.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1St2Nd3Rd Fl Nr. Raj Bunglow Nr.Safal Profitaire Prahlad Nagar Satellite, Ahmedabad, Gujarat, India – 380015
- IndustryAgriculture, Crop Protection
To see the full contact details of Meghmani Organics Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Meghmani Organics operates two associated brands: Epigral and Meghmani Organics Ltd. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Essential derivatives and specialty chemicals are manufactured for various industries. | epigral.com | |
| Meghmani Organics Ltd is engaged in chemical and agrochemical manufacturing. | meghmani.com |
Business activity
The main business activity of Meghmani Organics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Meghmani Organics Limited, buy the company report.
Financials of Meghmani Organics Limited
FY 2025-26 filings availableMeghmani Organics Limited reported revenue of ₹2,173.96 Cr (up 4.5% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2,174 | 2,080 | 1,566 | 2,553 | 2,498 | 1,637 | 700 |
| Revenue growth | +4.5% | +32.8% | -38.6% | +2.2% | +52.7% | +134.0% | - |
| EBITDA | 176 | 143 | (20.29) | 341 | 379 | 282 | 104 |
| EBITDA margin | +8.1% | +6.9% | -1.3% | +13.4% | +15.2% | +17.3% | +14.9% |
| Profit before tax | 62.05 | 9.47 | (121) | 313 | 409 | 252 | 194 |
| Net profit | 29.12 | (12.13) | (107) | 223 | 298 | 181 | 87.71 |
| Net profit margin | +1.3% | -0.6% | -6.9% | +8.8% | +11.9% | +11.1% | +12.5% |
| EPS (₹) | 1.13 | (0.42) | (4.17) | 9.35 | 11.97 | 7.33 | 11.76 |
| Balance sheet | |||||||
| Total assets | 2,304 | 2,370 | 2,400 | 2,532 | 1,989 | 1,456 | 1,268 |
| Net worth | 1,545 | 1,515 | 1,528 | 1,669 | 1,466 | 1,173 | 986 |
| Total debt | 726 | 829 | 837 | 824 | 499 | 268 | 264 |
| Cash & bank | 25.47 | 31.18 | 20.26 | 32.64 | 11.26 | 21.49 | 9.13 |
| Net working capital | 653 | 692 | 594 | 826 | 689 | 418 | 509 |
| Cash flow | |||||||
| Cash from operations | 222 | 66.22 | 250 | 204 | 64.83 | 333 | 21.92 |
| Cash from investing | (38.31) | 30.97 | (178) | (418) | (133) | (307) | 12.99 |
| Cash from financing | (190) | (91.39) | (85.48) | 234 | 57.72 | (14.24) | (26.42) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 667 | 543 | 474 | 509 | 577 | 614 | 553 | 569 |
| Revenue growth (YoY) | +15.5% | -11.5% | -14.3% | -10.5% | +6.1% | +48.3% | - | - |
| Other income | 20.07 | 11.93 | 37.24 | 14.84 | 27.76 | 16.58 | 13.88 | 9.14 |
| EBITDA | 73.14 | 97.91 | 19.72 | 37.74 | 52.10 | 66.88 | 65.48 | 40.82 |
| EBITDA margin | +11.0% | +18.0% | +4.2% | +7.4% | +9.0% | +10.9% | +11.8% | +7.2% |
| Depreciation | 30.29 | 29.80 | 29.33 | 29.94 | 29.98 | 29.70 | 29.49 | 29.67 |
| Interest | 14.97 | 13.05 | 20.48 | 18.13 | 23.78 | 29.47 | 19.32 | 12.88 |
| Profit before tax | 47.95 | 66.99 | 7.15 | 4.51 | 26.10 | 24.29 | 30.55 | 7.41 |
| Tax | 14.07 | 18.79 | (0.89) | 8.04 | 14.54 | 11.61 | 10.73 | 11.80 |
| Net profit | 33.88 | 48.20 | 8.04 | (3.53) | 11.56 | 12.68 | 19.82 | (4.39) |
| EPS (₹) | 1.33 | 1.90 | 0.32 | (0.14) | 0.45 | 0.50 | 0.78 | (0.17) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2,092 | 2,004 | 1,540 | 2,557 | 2,494 | 1,623 | 693 |
| Revenue growth | +4.4% | +30.1% | -39.8% | +2.5% | +53.6% | +134.2% | - |
| EBITDA | 229 | 180 | 9.45 | 364 | 379 | 280 | 103 |
| EBITDA margin | +10.9% | +9.0% | +0.6% | +14.2% | +15.2% | +17.2% | +14.9% |
| Profit before tax | 162 | 84.89 | (74.18) | 327 | 412 | 249 | 201 |
| Net profit | 126 | 67.51 | (57.82) | 250 | 302 | 180 | 94.05 |
| Net profit margin | +6.0% | +3.4% | -3.8% | +9.8% | +12.1% | +11.1% | +13.6% |
| EPS (₹) | 4.93 | 2.61 | (2.22) | 9.85 | 12.11 | 7.28 | 12.32 |
| Balance sheet | |||||||
| Total assets | 2,321 | 2,233 | 2,195 | 2,384 | 1,956 | 1,450 | 1,264 |
| Net worth | 1,758 | 1,632 | 1,565 | 1,656 | 1,440 | 1,167 | 982 |
| Total debt | 532 | 576 | 602 | 696 | 499 | 268 | 264 |
| Cash & bank | 22.48 | 27.16 | 17.51 | 29.17 | 9.83 | 21.11 | 8.33 |
| Net working capital | 637 | 614 | 522 | 819 | 699 | 412 | 504 |
| Cash flow | |||||||
| Cash from operations | 229 | 125 | 339 | 264 | 68.66 | 333 | 18.28 |
| Cash from investing | (124) | (40.84) | (176) | (356) | (267) | (306) | 15.79 |
| Cash from financing | (111) | (79.67) | (177) | 111 | 187 | (14.21) | (26.38) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 658 | 523 | 457 | 485 | 558 | 593 | 502 | 558 |
| Revenue growth (YoY) | +18.0% | -11.8% | -9.1% | -13.1% | +4.7% | +44.2% | - | - |
| Other income | 20.69 | 12.22 | 33.78 | 14.44 | 27.89 | 17.43 | 14.42 | 9.97 |
| Total expenses | 587 | 429 | 430 | 433 | 487 | 512 | 438 | 498 |
| EBITDA | 70.89 | 93.68 | 26.24 | 51.47 | 70.47 | 80.56 | 64.55 | 60.38 |
| EBITDA margin | +10.8% | +17.9% | +5.7% | +10.6% | +12.6% | +13.6% | +12.9% | +10.8% |
| Depreciation | 22.30 | 21.90 | 21.56 | 22.00 | 22.05 | 21.86 | 21.73 | 21.74 |
| Interest | 11.15 | 9.13 | 16.71 | 13.58 | 18.81 | 24.13 | 13.62 | 6.50 |
| Profit before tax | 58.13 | 74.87 | 21.75 | 30.33 | 57.50 | 52.00 | 43.62 | 42.11 |
| Tax | 12.81 | 17.27 | 2.21 | 8.04 | 14.59 | 11.48 | 9.65 | 11.94 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 667 | 543 | 474 | 509 | 577 | 614 | 553 | 569 |
| Revenue growth (YoY) | +15.5% | -11.5% | -14.3% | -10.5% | +6.1% | +48.3% | - | - |
| Other income | 20.07 | 11.93 | 37.24 | 14.84 | 27.76 | 16.58 | 13.88 | 9.14 |
| EBITDA | 73.14 | 97.91 | 19.72 | 37.74 | 52.10 | 66.88 | 65.48 | 40.82 |
| EBITDA margin | +11.0% | +18.0% | +4.2% | +7.4% | +9.0% | +10.9% | +11.8% | +7.2% |
| Depreciation | 30.29 | 29.80 | 29.33 | 29.94 | 29.98 | 29.70 | 29.49 | 29.67 |
| Interest | 14.97 | 13.05 | 20.48 | 18.13 | 23.78 | 29.47 | 19.32 | 12.88 |
| Profit before tax | 47.95 | 66.99 | 7.15 | 4.51 | 26.10 | 24.29 | 30.55 | 7.41 |
| Tax | 14.07 | 18.79 | (0.89) | 8.04 | 14.54 | 11.61 | 10.73 | 11.80 |
| Net profit | 33.88 | 48.20 | 8.04 | (3.53) | 11.56 | 12.68 | 19.82 | (4.39) |
| EPS (₹) | 1.33 | 1.90 | 0.32 | (0.14) | 0.45 | 0.50 | 0.78 | (0.17) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,174 | 2,080 | 1,566 | 2,553 | 2,498 | 1,637 | 700 |
| Revenue growth | +4.5% | +32.8% | -38.6% | +2.2% | +52.7% | +134.0% | - |
| Other income | 96.42 | 43.87 | 37.68 | 115 | 102 | 31.22 | 131 |
| Total expenses | 1,998 | 1,937 | 1,587 | 2,212 | 2,120 | 1,354 | 595 |
| Employee cost | 129 | 113 | 113 | 108 | 93.46 | 83.56 | 31.32 |
| EBITDA | 176 | 143 | (20.29) | 341 | 379 | 282 | 104 |
| EBITDA margin | +8.1% | +6.9% | -1.3% | +13.4% | +15.2% | +17.3% | +14.9% |
| Depreciation | 119 | 108 | 92.22 | 77.06 | 62.65 | 50.68 | 22.41 |
| Interest | 91.86 | 69.01 | 46.36 | 65.73 | 9.41 | 11.19 | 18.29 |
| Profit before tax | 62.05 | 9.47 | (121) | 313 | 409 | 252 | 194 |
| Tax | 33.30 | 20.07 | (15.15) | 75.38 | 104 | 65.32 | 44.61 |
| Net profit | 29.12 | (12.13) | (107) | 223 | 298 | 181 | 87.71 |
| Net profit margin | +1.3% | -0.6% | -6.9% | +8.8% | +11.9% | +11.1% | +12.5% |
| EPS (₹) | 1.13 | (0.42) | (4.17) | 9.35 | 11.97 | 7.33 | 11.76 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 |
| Reserves & surplus | 1,519 | 1,490 | 1,502 | 1,644 | 1,441 | 1,148 | 961 |
| Shareholders' funds (net worth) | 1,545 | 1,515 | 1,528 | 1,669 | 1,466 | 1,173 | 986 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 703 | 768 | 703 | 703 | 315 | 222 | 230 |
| Unsecured loans | 22.61 | 61.15 | 134 | 121 | 184 | 45.90 | 33.69 |
| Total debt | 726 | 829 | 837 | 824 | 499 | 268 | 264 |
| Total liabilities | 2,304 | 2,370 | 2,400 | 2,532 | 1,989 | 1,456 | 1,268 |
| Assets | |||||||
| Gross block | 2,168 | 2,142 | 1,619 | 1,545 | 1,220 | 884 | 682 |
| Net block | 1,494 | 1,575 | 1,152 | 1,166 | 911 | 634 | 481 |
| Capital work in progress | 87.08 | 82.55 | 521 | 356 | 188 | 112 | 101 |
| Investments | 4.59 | 3.21 | 114 | 183 | 211 | 304 | 191 |
| Inventories | 529 | 599 | 517 | 652 | 639 | 376 | 304 |
| Sundry debtors | 672 | 567 | 433 | 523 | 543 | 411 | 461 |
| Cash & bank balances | 25.47 | 31.18 | 20.26 | 32.64 | 11.26 | 21.49 | 9.13 |
| Loans & advances | 87.96 | 153 | 227 | 228 | 243 | 83.98 | 78.80 |
| Total current assets | 1,314 | 1,350 | 1,197 | 1,436 | 1,437 | 892 | 853 |
| Total current liabilities | 661 | 658 | 603 | 610 | 748 | 474 | 344 |
| Net working capital | 653 | 692 | 594 | 826 | 689 | 418 | 509 |
| Total assets | 2,304 | 2,370 | 2,400 | 2,532 | 1,989 | 1,456 | 1,268 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 22.68 | 16.88 | 31.06 | 10.49 | 20.72 | 8.49 | 0.00 |
| Net cash from operating activities | 222 | 66.22 | 250 | 204 | 64.83 | 333 | 21.92 |
| Net cash from investing activities | (38.31) | 30.97 | (178) | (418) | (133) | (307) | 12.99 |
| Net cash from financing activities | (190) | (91.39) | (85.48) | 234 | 57.72 | (14.24) | (26.42) |
| Net change in cash | (6.87) | 5.80 | (14.18) | 20.57 | (10.23) | 12.22 | 8.49 |
| Closing cash | 25.47 | 31.18 | 20.26 | 32.64 | 11.26 | 21.49 | 9.13 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +4.5% | +32.8% | -38.6% | +2.2% | +52.7% | +134.0% | - |
| EBITDA growth | +23.6% | +803.5% | -106.0% | -9.9% | +34.0% | +171.3% | - |
| PBT growth | +555.2% | +9998.0% | - | -23.4% | +62.4% | -35.2% | +9997.0% |
| Net income growth | +340.1% | +88.7% | -148.0% | -25.1% | +64.8% | +106.3% | - |
| Revenue CAGR (3Y) | -5.2% | -5.9% | -1.5% | +54.0% | - | - | - |
| EBITDA CAGR (3Y) | -19.7% | -27.8% | - | +48.5% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +1.3% | -0.5% | -6.8% | +9.3% | +12.2% | +11.4% | +21.4% |
| Return on capital employed | +6.6% | +3.4% | -3.0% | +16.8% | +24.3% | +19.3% | +20.8% |
| Return on net worth | +1.9% | -0.8% | -6.6% | +15.2% | +23.1% | +17.3% | +17.8% |
| Debt / equity | 0.51 | 0.55 | 0.52 | 0.42 | 0.29 | 0.25 | 0.27 |
| Long-term debt / equity | 0.15 | 0.27 | 0.34 | 0.24 | 0.13 | 0.09 | 0.06 |
| Interest cover | 159.78 | 199.39 | -41.21 | 24.90 | 2.98 | 4.83 | 22.39 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.01 | 1.11 | 0.99 | 1.85 | 2.37 | 2.09 | 2.05 |
| Inventory turnover | 3.86 | 3.73 | 2.68 | 3.95 | 4.92 | 4.82 | 4.61 |
| Debtors turnover | 3.51 | 4.16 | 3.28 | 4.79 | 5.24 | 3.76 | 3.03 |
| EPS (₹) | 1.13 | (0.42) | (4.17) | 9.35 | 11.97 | 7.33 | 11.76 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 1.40 | 1.40 | 1.40 | 1.00 |
| Book value per share (₹) | 60.74 | 59.58 | 60.07 | 65.64 | 57.65 | 46.13 | 38.79 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 658 | 523 | 457 | 485 | 558 | 593 | 502 | 558 |
| Revenue growth (YoY) | +18.0% | -11.8% | -9.1% | -13.1% | +4.7% | +44.2% | - | - |
| Other income | 20.69 | 12.22 | 33.78 | 14.44 | 27.89 | 17.43 | 14.42 | 9.97 |
| Total expenses | 587 | 429 | 430 | 433 | 487 | 512 | 438 | 498 |
| EBITDA | 70.89 | 93.68 | 26.24 | 51.47 | 70.47 | 80.56 | 64.55 | 60.38 |
| EBITDA margin | +10.8% | +17.9% | +5.7% | +10.6% | +12.6% | +13.6% | +12.9% | +10.8% |
| Depreciation | 22.30 | 21.90 | 21.56 | 22.00 | 22.05 | 21.86 | 21.73 | 21.74 |
| Interest | 11.15 | 9.13 | 16.71 | 13.58 | 18.81 | 24.13 | 13.62 | 6.50 |
| Profit before tax | 58.13 | 74.87 | 21.75 | 30.33 | 57.50 | 52.00 | 43.62 | 42.11 |
| Tax | 12.81 | 17.27 | 2.21 | 8.04 | 14.59 | 11.48 | 9.65 | 11.94 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,092 | 2,004 | 1,540 | 2,557 | 2,494 | 1,623 | 693 |
| Revenue growth | +4.4% | +30.1% | -39.8% | +2.5% | +53.6% | +134.2% | - |
| Other income | 93.54 | 43.57 | 42.94 | 95.96 | 102 | 31.22 | 138 |
| Total expenses | 1,863 | 1,824 | 1,530 | 2,193 | 2,115 | 1,344 | 590 |
| Employee cost | 106 | 92.75 | 97.81 | 99.57 | 90.90 | 81.59 | 30.50 |
| EBITDA | 229 | 180 | 9.45 | 364 | 379 | 280 | 103 |
| EBITDA margin | +10.9% | +9.0% | +0.6% | +14.2% | +15.2% | +17.2% | +14.9% |
| Depreciation | 87.47 | 85.61 | 83.14 | 68.11 | 59.99 | 50.65 | 22.40 |
| Interest | 73.22 | 53.43 | 43.43 | 64.41 | 9.33 | 11.16 | 18.25 |
| Profit before tax | 162 | 84.89 | (74.18) | 327 | 412 | 249 | 201 |
| Tax | 36.33 | 18.44 | (17.60) | 77.05 | 104 | 64.32 | 44.46 |
| Net profit | 126 | 67.51 | (57.82) | 250 | 302 | 180 | 94.05 |
| Net profit margin | +6.0% | +3.4% | -3.8% | +9.8% | +12.1% | +11.1% | +13.6% |
| EPS (₹) | 4.93 | 2.61 | (2.22) | 9.85 | 12.11 | 7.28 | 12.32 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 |
| Reserves & surplus | 1,733 | 1,607 | 1,539 | 1,631 | 1,415 | 1,142 | 957 |
| Shareholders' funds (net worth) | 1,758 | 1,632 | 1,565 | 1,656 | 1,440 | 1,167 | 982 |
| Secured loans | 510 | 514 | 566 | 704 | 315 | 222 | 230 |
| Unsecured loans | 22.61 | 61.15 | 35.17 | (7.93) | 184 | 45.90 | 33.69 |
| Total debt | 532 | 576 | 602 | 696 | 499 | 268 | 264 |
| Total liabilities | 2,321 | 2,233 | 2,195 | 2,384 | 1,956 | 1,450 | 1,264 |
| Assets | |||||||
| Gross block | 1,510 | 1,487 | 1,391 | 1,365 | 1,041 | 883 | 681 |
| Net block | 912 | 964 | 945 | 999 | 735 | 633 | 481 |
| Capital work in progress | 77.66 | 72.18 | 148 | 145 | 187 | 112 | 101 |
| Investments | 685 | 591 | 575 | 443 | 348 | 306 | 192 |
| Inventories | 504 | 557 | 481 | 618 | 628 | 373 | 296 |
| Sundry debtors | 653 | 528 | 433 | 541 | 543 | 406 | 464 |
| Cash & bank balances | 22.48 | 27.16 | 17.51 | 29.17 | 9.83 | 21.11 | 8.33 |
| Loans & advances | 63.91 | 92.49 | 147 | 187 | 232 | 83.95 | 78.61 |
| Total current assets | 1,243 | 1,204 | 1,078 | 1,375 | 1,413 | 884 | 847 |
| Total current liabilities | 606 | 589 | 556 | 556 | 715 | 472 | 343 |
| Net working capital | 637 | 614 | 522 | 819 | 699 | 412 | 504 |
| Total assets | 2,321 | 2,233 | 2,195 | 2,384 | 1,956 | 1,450 | 1,264 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 18.66 | 14.13 | 27.59 | 9.06 | 20.34 | 7.69 | 0.00 |
| Net cash from operating activities | 229 | 125 | 339 | 264 | 68.66 | 333 | 18.28 |
| Net cash from investing activities | (124) | (40.84) | (176) | (356) | (267) | (306) | 15.79 |
| Net cash from financing activities | (111) | (79.67) | (177) | 111 | 187 | (14.21) | (26.38) |
| Net change in cash | (5.84) | 4.54 | (13.46) | 18.52 | (11.28) | 12.64 | 7.69 |
| Closing cash | 22.48 | 27.16 | 17.51 | 29.17 | 9.83 | 21.11 | 8.33 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +4.4% | +30.1% | -39.8% | +2.5% | +53.6% | +134.2% | - |
| EBITDA growth | +26.8% | +1808.6% | -97.4% | -4.1% | +35.6% | +171.1% | - |
| PBT growth | +90.3% | +9998.0% | - | -20.6% | +65.4% | -38.0% | +9997.0% |
| Net income growth | +86.7% | +216.8% | -123.1% | -17.1% | +68.1% | +90.9% | - |
| Revenue CAGR (3Y) | -6.5% | -7.0% | -1.8% | +54.5% | - | - | - |
| EBITDA CAGR (3Y) | -14.4% | -22.0% | -67.7% | +52.2% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +6.0% | +3.3% | -3.7% | +9.8% | +12.4% | +11.4% | +22.6% |
| Return on capital employed | +10.3% | +6.3% | -1.3% | +18.1% | +24.8% | +19.2% | +22.0% |
| Return on net worth | +7.4% | +4.2% | -3.5% | +16.2% | +23.6% | +17.2% | +19.2% |
| Debt / equity | 0.33 | 0.37 | 0.40 | 0.39 | 0.29 | 0.25 | 0.27 |
| Long-term debt / equity | 0.04 | 0.09 | 0.14 | 0.16 | 0.13 | 0.09 | 0.06 |
| Interest cover | 51.83 | 56.39 | -58.94 | 21.77 | 2.92 | 4.87 | 22.57 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.40 | 1.39 | 1.12 | 2.12 | 2.59 | 2.08 | 2.04 |
| Inventory turnover | 3.95 | 3.86 | 2.80 | 4.10 | 4.98 | 4.85 | 4.68 |
| Debtors turnover | 3.55 | 4.17 | 3.16 | 4.72 | 5.26 | 3.73 | 2.99 |
| EPS (₹) | 4.93 | 2.61 | (2.22) | 9.85 | 12.11 | 7.28 | 12.32 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 1.40 | 1.40 | 1.40 | 1.00 |
| Book value per share (₹) | 69.14 | 64.18 | 61.53 | 65.12 | 56.63 | 45.90 | 38.62 |
To see the full year-wise statements and ratios of Meghmani Organics Limited, buy the company report.
Board of directors and KMP of Meghmani Organics Limited
Meghmani Organics Limited currently reports 10 directors and 2 key managerial personnel. 6 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karana Rameshbhai Patel Also directs: Epigral Limited, Navratan Specialty Chemicals LLP, Uniworth Enterprises LLP and 5 more | Whole-Time Director | 14 Aug 2023 | 3 Years 3 Months | Current |
| Maulik Jayantibhai Patel Also directs: Epigral Limited, Meghmani Crop Nutrition Limited, Kilburn Chemicals Limited and 5 more | Director | 14 Aug 2023 | 3 Years 3 Months | Current |
| Ankit Natwarlal Patel Also directs: Epigral Limited, Uniworth Enterprises LLP, Meghmani Dyes and Intermediates LLP and 5 more | Managing Director | 14 Aug 2023 | 3 Years 3 Months | Current |
| Manubhai Khodidas Patel Also directs: Epigral Limited, Acme Diet Care Private Limited, Dialforhealth Unity Limited and 5 more | Director | 07 May 2021 | 5 Years 6 Months | Current |
| Nikunt Kirit Raval Also directs: Themis Medicare Limited | Director | 07 Nov 2023 | 3 Years 0 Months | Current |
| Darshan Anandbhai Patel Also directs: Epigral Limited, Meghmani Crop Nutrition Limited, Kilburn Chemicals Limited and 4 more | Whole-Time Director | 14 Aug 2023 | 3 Years 3 Months | Current |
Peer comparison
Meghmani Organics Limited is compared with the 3 companies closest to it by revenue in the Agriculture industry (Dyes and Pigments, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meghmani Organics Limitedthis company | ₹2,173.96 Cr (FY 2026) | ₹29.12 Cr | 1.3% | 4.5% | 1,701 | Ahmedabad, Gujarat, India |
| Meghmani Organics Limited | ₹2,123.62 Cr (FY 2025) | 32.0% | Ahmedabad, Gujarat, India | |||
| Willowood Chemicals Limited | ₹2,111.28 Cr (FY 2025) | 16.0% | Kolkata, West Bengal, India | |||
| Jay Chemical Industries Private Limited | ₹1,670.11 Cr (FY 2025) | 19.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Meghmani Organics Limited, buy the company report.
Auditor
Meghmani Organics Limited is audited by S R B C & CO LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2024 | 324982E |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 49.00%, foreign institutional investors hold 0.90%, domestic institutional investors hold 0.10% and retail and other public shareholders hold 50.10%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 49.00% | 49.00% | 49.00% | 49.00% |
| Public | 51.00% | 51.00% | 51.00% | 51.00% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Nov 2025 | 101184671 | Others | ₹70 Cr | Open | |
| 27 Dec 2024 | 101026872 | Others | ₹36 Cr | Open | |
| 09 Nov 2023 | 100817834 | Sbicap Trustee Company Limited | ₹150 Cr | Open | |
| 27 Mar 2023 | 100750545 | Others | ₹150 Cr | Open | |
| 01 Sep 2022 | 100628697 | Sbicap Trustee Company Limited | ₹150 Cr | Open |
To see the full charge records of Meghmani Organics Limited, buy the company report.
Total charge records: 13 View all charges
Legal cases
Meghmani Organics Limited has 324 court cases on record: 229 filed by Meghmani Organics, 95 filed against it. 80 cases are pending and 244 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 217 | 29 | 71 |
| High courts | 87 | 46 | 8 |
| Supreme Court | 19 | 19 | 1 |
| NCLAT | 1 | 1 | 0 |
Cases on record (5 of 324)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against Aryan Crop Protection Pvt Ltd and 1 other | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against Aadhar Agro Chemicals LLP and 3 others | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed by the company against Aadhar Agro Chemicals LLP and 3 others | Disposed |
| High Court, GUJARAT | Special civil application | Filed against the company by Syngenta India Limited and 1 other | Disposed |
| High Court, GUJARAT | Special civil application | Filed against the company by Makhteshim-Agan India Pvt Ltd and 1 other | Disposed |
To see the full case history of Meghmani Organics Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Meghmani Organics Limited has 9 MSME Form 1 returns on record between 2021 and 2024, listing 1,711 overdue payments to 147 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 147)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Thermotech Engineering India LLP | |||
| Asian Sky Infrastructure Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Meghmani Organics Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Meghmani Organics has 2 subsidiary companies. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Inc Meghmani Crop Nutrition Limited | U24110GJ2021PLC119809 | |
| Kilburn Chemicals Limited | U24117GJ1990PLC135801 |
To see the full group structure of Meghmani Organics Limited, buy the company report.
Employees & EPFO
Meghmani Organics Limited has a workforce of 1,701 employees on its EPFO records as of May 2026, across 6 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 1,701 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2014-15 |
To see the full employee and EPFO history of Meghmani Organics Limited, buy the company report.
GST
Meghmani Organics has 21 GST registrations: 18 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AANCM0056E1ZR | Gujarat | Active | 01 Feb 2020 |
| 24AANCM0056E2ZQ | Gujarat | Active | 05 May 2021 |
| 24AANCM0056E3ZP | Gujarat | Active | 05 May 2021 |
| 06AANCM0056E1ZP | Haryana | Active | 05 May 2021 |
To see the full GST registrations and return filing status of Meghmani Organics Limited, buy the company report.
Recent activity
Meghmani Organics Limited has 18 board changes on record since 2021: 12 appointments and 6 cessations. The latest: Nareshkumar Jashvantbhai Prajapati was appointed as Company Secretary on 29 Jul 2026.
30 earlier events are in the company report.
News
Frequently asked questions
Meghmani Organics is an active public limited company based in Ahmedabad, Gujarat, India. The company works in crop protection, within the agriculture industry. It was incorporated on 15 October 2019 (7+ years old) and is registered under CIN L24299GJ2019PLC110321. Listed on BSE: 543331 and NSE: MOL.
Meghmani Organics reported revenue of ₹2,173.96 Cr for FY 2025-26 (up 4.5% YoY) based on consolidated financials.
Meghmani Organics has 12 current directors and KMP:
- Ankit Natwarlal Patel - Managing Director
- Karana Rameshbhai Patel - Whole-Time Director
- Darshan Anandbhai Patel - Whole-Time Director
- Maulik Jayantibhai Patel - Director
- Manubhai Khodidas Patel - Director
- Nikunt Kirit Raval - Director
- Varesh Sinha - Director
- Ganapathi Dadasaheb Yadav - Director
- Kaushal Ashishbhai Soparkar - Director
- Urvashi Dhirubhai Shah - Director
- Nareshkumar Jashvantbhai Prajapati - Company Secretary
- Gurjant Singh Chahal - Cfo
The latest financial statements of Meghmani Organics on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 28 June 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Meghmani Organics is 24AANCM0056E1ZR, registered in Gujarat. The company has 21 GST registrations in all, of which 18 are active and 3 are cancelled or inactive. Other active GSTINs include 24AANCM0056E2ZQ (Gujarat), 24AANCM0056E3ZP (Gujarat), 06AANCM0056E1ZP (Haryana).
The CIN (Corporate Identification Number) of Meghmani Organics is L24299GJ2019PLC110321. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Meghmani Organics is a listed company as per MCA records. Its shares are listed on both BSE (code: 543331) and NSE (symbol: MOL).
Meghmani Organics has 324 court cases on record: 229 filed by the company and 95 filed against it. 80 are pending. Most are in the district courts.
Meghmani Organics was incorporated on 15 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Meghmani Organics by revenue are Meghmani Organics, Willowood Chemicals Limited, Jay Chemical Industries Private Limited, all in the Agriculture industry (Dyes and Pigments, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nareshkumar Jashvantbhai Prajapati was appointed as Company Secretary on 29 Jul 2026. Nikunt Kirit Raval was appointed as Director on 07 Nov 2023. Shalin Niranjanbhai Mehta ceased to be Director on 07 Nov 2023. Meghmani Organics has 18 board changes on record in total.
Meghmani Organics has 9 MSME Form 1 returns on record between 2021 and 2024, listing 1,711 overdue payments to 147 micro and small suppliers. The latest return was filed on 24 Apr 2024.

